Group 1 - The core viewpoint of the article highlights McKesson's financial performance, showing a significant increase in revenue but a decline in net profit [1][2] - As of June 30, 2025, McKesson reported total revenue of $97.827 billion, representing a year-over-year growth of 23.39% [1] - The company's net profit attributable to shareholders was $784 million, which reflects a year-over-year decrease of 14.32% [1] Group 2 - On August 6, McKesson announced a cumulative share repurchase amounting to $581 million for the first quarter of 2025 [2] - McKesson is recognized as a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology, specialty care, and healthcare information technology [2] - The company operates through three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions [2]